ImmunovantInc Cash and Equivalents vs Tax Assets Analysis

IMVT Stock  USD 32.31  0.21  0.65%   
Trend analysis of ImmunovantInc balance sheet accounts such as Total Stockholder Equity of 241.3 M or Net Tangible Assets of 242.7 M provides information on ImmunovantInc's total assets, liabilities, and equity, which is the actual value of ImmunovantInc to its prevalent stockholders. By breaking down trends over time using ImmunovantInc balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ImmunovantInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
For more information on how to buy ImmunovantInc Stock please use our How to Invest in ImmunovantInc guide.

About ImmunovantInc Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of ImmunovantInc at a specified time, usually calculated after every quarter, six months, or one year. ImmunovantInc Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of ImmunovantInc and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which ImmunovantInc currently owns. An asset can also be divided into two categories, current and non-current.

ImmunovantInc Balance Sheet Chart

ImmunovantInc Balance Sheet is one of the main financial statements that report all assets, liabilities, and shareholders' equity for the current year. It provides a basis for different types of computing rates of return, such as return on equity (ROE) or return on asset (ROA), as well as shows how ImmunovantInc uses and utilizes its capital. It also shows what exactly a company owns and owes.
At this time, ImmunovantInc's Short Term Debt is comparatively stable compared to the past year. Capital Lease Obligations is likely to gain to about 1.9 M in 2024, whereas Net Tangible Assets are likely to drop slightly above 242.7 M in 2024.

Total Assets

Total assets refers to the total amount of ImmunovantInc assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in ImmunovantInc books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on ImmunovantInc balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of ImmunovantInc are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Accounts Payable

An accounting item on the balance sheet that represents ImmunovantInc obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of ImmunovantInc are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Common Stock Shares Outstanding

The total number of shares of a company's common stock that are currently owned by all its shareholders.
Most indicators from ImmunovantInc's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into ImmunovantInc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ImmunovantInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
For more information on how to buy ImmunovantInc Stock please use our How to Invest in ImmunovantInc guide.At this time, ImmunovantInc's Tax Provision is comparatively stable compared to the past year. Issuance Of Capital Stock is likely to gain to about 78.1 M in 2024, whereas Selling General Administrative is likely to drop slightly above 30.1 M in 2024.
 2021 2022 2023 2024 (projected)
Total Operating Expenses156.0M208.3M239.5M123.8M
Research Development101.8M160.3M184.3M98.9M

ImmunovantInc fundamental ratios Correlations

0.891.01.00.560.910.910.91.00.710.830.92-0.9-0.98-0.881.00.920.921.00.20.980.020.970.73-0.91.0
0.890.890.890.430.980.991.00.890.610.980.74-0.86-0.91-0.980.910.740.840.910.10.940.00.940.91-0.890.91
1.00.891.00.560.910.910.91.00.710.820.93-0.9-0.98-0.881.00.930.911.00.190.970.020.970.72-0.91.0
1.00.891.00.560.910.910.91.00.710.820.93-0.9-0.98-0.881.00.930.911.00.190.970.010.970.72-0.91.0
0.560.430.560.560.350.360.440.560.360.220.52-0.41-0.57-0.310.560.520.390.560.910.430.00.430.02-0.380.55
0.910.980.910.910.351.00.990.910.660.980.81-0.88-0.93-0.970.930.810.860.93-0.010.95-0.010.940.92-0.910.93
0.910.990.910.910.361.00.990.910.630.980.8-0.86-0.93-0.980.930.80.840.930.00.95-0.060.950.93-0.890.93
0.91.00.90.90.440.990.990.910.630.970.76-0.87-0.92-0.980.920.760.840.920.10.940.00.940.9-0.90.92
1.00.891.01.00.560.910.910.910.70.830.92-0.9-0.98-0.881.00.920.921.00.20.980.020.970.73-0.91.0
0.710.610.710.710.360.660.630.630.70.570.76-0.89-0.75-0.540.720.780.840.720.080.690.590.60.46-0.880.72
0.830.980.820.820.220.980.980.970.830.570.67-0.83-0.84-0.980.840.670.810.84-0.110.910.010.90.98-0.870.84
0.920.740.930.930.520.810.80.760.920.760.67-0.81-0.94-0.720.931.00.790.930.140.85-0.050.820.57-0.810.93
-0.9-0.86-0.9-0.9-0.41-0.88-0.86-0.87-0.9-0.89-0.83-0.810.910.83-0.9-0.82-0.98-0.9-0.07-0.92-0.4-0.87-0.731.0-0.9
-0.98-0.91-0.98-0.98-0.57-0.93-0.93-0.92-0.98-0.75-0.84-0.940.910.89-0.99-0.94-0.88-0.99-0.2-0.95-0.01-0.94-0.740.91-0.99
-0.88-0.98-0.88-0.88-0.31-0.97-0.98-0.98-0.88-0.54-0.98-0.720.830.89-0.89-0.72-0.82-0.890.04-0.940.07-0.95-0.940.86-0.89
1.00.911.01.00.560.930.930.921.00.720.840.93-0.9-0.99-0.890.930.911.00.190.980.010.970.74-0.911.0
0.920.740.930.930.520.810.80.760.920.780.671.0-0.82-0.94-0.720.930.80.930.140.85-0.010.820.57-0.820.93
0.920.840.910.910.390.860.840.840.920.840.810.79-0.98-0.88-0.820.910.80.910.060.940.390.90.71-0.970.91
1.00.911.01.00.560.930.930.921.00.720.840.93-0.9-0.99-0.891.00.930.910.190.980.010.970.74-0.911.0
0.20.10.190.190.91-0.010.00.10.20.08-0.110.14-0.07-0.20.040.190.140.060.190.060.040.08-0.31-0.040.18
0.980.940.970.970.430.950.950.940.980.690.910.85-0.92-0.95-0.940.980.850.940.980.060.070.990.83-0.930.98
0.020.00.020.010.0-0.01-0.060.00.020.590.01-0.05-0.4-0.010.070.01-0.010.390.010.040.07-0.03-0.07-0.370.01
0.970.940.970.970.430.940.950.940.970.60.90.82-0.87-0.94-0.950.970.820.90.970.080.99-0.030.84-0.880.97
0.730.910.720.720.020.920.930.90.730.460.980.57-0.73-0.74-0.940.740.570.710.74-0.310.83-0.070.84-0.780.74
-0.9-0.89-0.9-0.9-0.38-0.91-0.89-0.9-0.9-0.88-0.87-0.811.00.910.86-0.91-0.82-0.97-0.91-0.04-0.93-0.37-0.88-0.78-0.91
1.00.911.01.00.550.930.930.921.00.720.840.93-0.9-0.99-0.891.00.930.911.00.180.980.010.970.74-0.91
Click cells to compare fundamentals

ImmunovantInc Account Relationship Matchups

ImmunovantInc fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets109.4M412.5M515.6M405.8M466.7M264.7M
Total Current Liabilities15.3M18.8M44.5M43.3M49.8M52.3M
Total Stockholder Equity94.1M391.5M469.8M362.5M416.9M241.3M
Net Tangible Assets94.1M391.5M469.8M362.5M416.9M242.7M
Accounts Payable1.2M2.4M18.6M1.4M1.6M1.5M
Common Stock Shares Outstanding43.2M87.8M109.7M123.1M141.5M148.6M
Other Stockholder Equity185.3M590.4M824.8M928.0M1.1B1.1B
Total Liab15.3M21.0M45.7M43.3M49.8M52.3M
Total Current Assets109.1M409.0M512.9M404.3M465.0M263.2M
Short Long Term Debt Total3.2M3.4M2.4M1.2M1.4M2.3M
Other Current Liab14.1M15.2M24.7M40.8M46.9M49.2M
Property Plant And Equipment Net65K3.5M2.6M1.5M1.7M1.7M
Net Debt(97.4M)(396.7M)(491.5M)(375.3M)(337.8M)(354.7M)
Retained Earnings(91.2M)(198.7M)(355.4M)(566.3M)(509.7M)(484.2M)
Cash100.6M400.1M493.8M376.5M433.0M301.7M
Non Current Assets Total311K3.5M2.6M1.5M1.7M1.8M
Cash And Short Term Investments100.6M400.1M493.8M376.5M433.0M301.7M
Net Receivables3.0M548K12.9M885K1.0M966.9K
Common Stock Total Equity5K10K12K13K15.0K8.9K
Liabilities And Stockholders Equity109.4M412.5M515.6M405.8M466.7M317.6M
Non Current Liabilities Total14.1M2.2M1.2M47K42.3K40.2K
Capital Surpluse185.3M590.4M824.8M928.0M1.1B556.3M
Other Current Assets5.5M8.3M6.3M26.9M31.0M32.5M
Net Invested Capital94.1M391.5M469.8M362.5M416.9M290.0M
Capital Stock5K10K12K13K15.0K8.9K
Net Working Capital93.8M390.2M468.4M361.0M415.2M288.9M
Short Term Debt3.2M1.2M1.1M1.2M1.1M1.1M
Common Stock5K10K12K13K15.0K8.9K
Property Plant Equipment65K201K330K333K383.0K216.3K

ImmunovantInc Investors Sentiment

The influence of ImmunovantInc's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in ImmunovantInc. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to ImmunovantInc's public news can be used to forecast risks associated with an investment in ImmunovantInc. The trend in average sentiment can be used to explain how an investor holding ImmunovantInc can time the market purely based on public headlines and social activities around ImmunovantInc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
ImmunovantInc's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for ImmunovantInc's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average ImmunovantInc's news discussions. The higher the estimated score, the more favorable is the investor's outlook on ImmunovantInc.

ImmunovantInc Implied Volatility

    
  59.45  
ImmunovantInc's implied volatility exposes the market's sentiment of ImmunovantInc stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if ImmunovantInc's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that ImmunovantInc stock will not fluctuate a lot when ImmunovantInc's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards ImmunovantInc in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, ImmunovantInc's short interest history, or implied volatility extrapolated from ImmunovantInc options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether ImmunovantInc is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if ImmunovantInc Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Immunovantinc Stock. Highlighted below are key reports to facilitate an investment decision about Immunovantinc Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in ImmunovantInc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in real.
For more information on how to buy ImmunovantInc Stock please use our How to Invest in ImmunovantInc guide.
You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Complementary Tools for ImmunovantInc Stock analysis

When running ImmunovantInc's price analysis, check to measure ImmunovantInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ImmunovantInc is operating at the current time. Most of ImmunovantInc's value examination focuses on studying past and present price action to predict the probability of ImmunovantInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ImmunovantInc's price. Additionally, you may evaluate how the addition of ImmunovantInc to your portfolios can decrease your overall portfolio volatility.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Is ImmunovantInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ImmunovantInc. If investors know ImmunovantInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ImmunovantInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.81)
Return On Assets
(0.27)
Return On Equity
(0.45)
The market value of ImmunovantInc is measured differently than its book value, which is the value of ImmunovantInc that is recorded on the company's balance sheet. Investors also form their own opinion of ImmunovantInc's value that differs from its market value or its book value, called intrinsic value, which is ImmunovantInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ImmunovantInc's market value can be influenced by many factors that don't directly affect ImmunovantInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ImmunovantInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if ImmunovantInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ImmunovantInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.